Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biogen
Pharma
Genentech awarded $124M in Cabilly patent dispute with Biogen
A California judge has ruled that Biogen owes Roche $124 million in royalties for its use of intellectual propery developed more than 40 years ago.
Kevin Dunleavy
Oct 6, 2025 3:37pm
Biogen-backed web series gets Bill Nye back in the lab
Sep 30, 2025 9:45am
Biogen undeterred after FDA snub for high-dose Spinraza in SMA
Sep 24, 2025 9:51am
Settlement allows Sandoz to launch Eylea biosimilar in late 2026
Sep 9, 2025 10:30am
Eisai scores FDA nod for subcutaneous Leqembi maintenance dose
Aug 29, 2025 5:55pm
Big Pharma bounces back in Q2
Aug 22, 2025 9:09am
